Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Energy Industry News IOCL entrusts McDermott with naphtha cracker expansion at Panipat Refinery McDermott has secured a project management consultancy (PMC) and engineering, procurement, and construction management (EPCM) contract for the… byPallavi MadhirajuAugust 1, 2023